Connect with us

Hi, what are you looking for?


China Jo-Jo Drugstores stock: Avoid this dilution machine

China Jo-Jo Drugstores (NASDAQ: CJJD) stock price has cratered as the future of the company remains in peril. The shares plunged to a low of $0.67, the lowest level in months. It has crashed by more than 87% from the highest point in March, giving it a market cap of over $3.6 million.

Dilution machine and bankruptcy risks

China Jo-Jo Drugstores is a small company that operates several pharmaceutical and drugstores in China. As its name suggests, the company deals with over-the-counter medicines, traditional drugs, amd medical devices. It also sells these drugs in a wholesale basis. 

China Jo-Jo has also been a dilution machine in the past few years. The number of outstanding shares has jumped from 658k in 2010 to almost 4 million today. And this week, the company said that it will continue diluting shareholders by raising $7 million. It will issue over 2.58 million shares at $3.10 per share.

Capital raising tends to have a direct impact of increasing the number of shares, meaning that existing holders are diluted. It is the exact opposite of share buybacks, which reduce the number of total outstanding shares. 

It is also worth noting that China Jo-Jo has become a penny store again, with its stock trading below $1. Last year, the company found itself in this similar situation, which risked its Nasdaq listing. As a result, the company decided to have a reverse split that pushed its shares to $9.64. 

Therefore, there are significant bankruptcy and compliance risks ahead. For one, a look at its website shows that it has not provided any meaningful disclosures to investors. The most recent financial statement came out in July last year when it published its fiscal year financial results. Those results showed that its revenue increased to $164.39 million while the net loss came in at $3.2 million.

Is China Jo-Jo stock a good buy?

I believe that China Jo-Jo is not a good investment. It is a penny stock that makes limited disclosures to investors. Also. there are challenges with disclosures considering that it is a Chinese company. As we saw with Luckin Coffee, small Chinese companies are difficult to evaluate well. 

Most importantly, China Jo-Jo is a dilution machine. There is a high possibility that it will raise more cash again soon. Therefore, I recommend avoiding the company and investing in quality alternatives like CVS and Walgreens.

The post China Jo-Jo Drugstores stock: Avoid this dilution machine appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Rep. Jennifer Wexton (D-Va.) announced on Tuesday that she has been diagnosed with Parkinson’s Disease. “If there’s one thing that Democrats and Republicans can...

    Latest News

    After Dianne Feinstein announced she’d contracted the shingles in early March, her staff said she planned to return to the Senate within a matter...


    A U.S. District Court judge has ruled that Elizabeth Holmes, founder and CEO of the disgraced blood-testing company Theranos, cannot remain free on bail...

    Latest News

    SEOUL, South Korea — When a group of American lawmakers arrived in South Korea for meetings with government and military officials, President Yoon Suk-yeol...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2022 All Rights Reserved.